![PRD_001128 PRD_001128](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001128.svg) | PRD_001128 | Name: | GRAMICIDIN C | Formula: | C101 H139 N19 O18 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-01 | Last modified: | 2013-07-01 |
|
![PRD_001129 PRD_001129](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001129.svg) | PRD_001129 | Name: | Microcin C7 analog | Formula: | C28 H51 N12 O11 S | Definition date: | 2013-07-01 | Last modified: | 2013-07-01 |
|
![PRD_001126 PRD_001126](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001126.svg) | PRD_001126 | Name: | Microcin C7 ANALOG | Formula: | C28 H51 N12 O11 Se | Definition date: | 2013-06-26 | Last modified: | 2013-06-26 |
|
![PRD_001122 PRD_001122](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001122.svg) | PRD_001122 | Name: | CYCLOSPORIN D | Formula: | C64 H115 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 7 TO BE N-METHYL-L-ALANINE. | Definition date: | 2013-06-20 | Last modified: | 2013-06-20 |
|
![PRD_001123 PRD_001123](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001123.svg) | PRD_001123 | Name: | CYCLOSPORIN C | Formula: | C64 H114 N10 O14 | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). THIS IS A CYCLOSPORIN C VARIANT THAT DIFFERS AT 1, 3, AND 9 POSITIONS. | Definition date: | 2013-06-20 | Last modified: | 2013-06-20 |
|
![PRD_001102 PRD_001102](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001102.svg) | PRD_001102 | Name: | M48U12 | Formula: | C133 H217 N39 O31 S6 | Definition date: | 2013-06-19 | Last modified: | 2013-06-19 |
|
![PRD_001108 PRD_001108](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001108.svg) | PRD_001108 | Name: | CYCLOSPORIN A | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 8 TO BE 4,N-DIMETHYLNORLEUCINE. | Definition date: | 2013-06-19 | Last modified: | 2013-06-19 |
|
![PRD_000925 PRD_000925](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000925.svg) | PRD_000925 | Name: | Caspase inhibitor | Formula: | C42 H58 N6 O12 | Definition date: | 2013-06-12 | Last modified: | 2013-06-12 |
|
![PRD_001094 PRD_001094](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001094.svg) | PRD_001094 | Name: | CD4-MIMETIC MINIPROTEIN M48U1 | Formula: | C133 H216 N38 O32 S6 | Definition date: | 2013-06-12 | Last modified: | 2013-06-12 |
|
![PRD_001099 PRD_001099](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001099.svg) | PRD_001099 | Name: | CD4-MIMETIC MINIPROTEIN M48U7 | Formula: | C131 H214 N38 O33 S6 | Definition date: | 2013-06-12 | Last modified: | 2013-06-12 |
|
![PRD_000995 PRD_000995](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000995.svg) | PRD_000995 | Name: | D-peptide inhibitor DPMI-delta | Formula: | C73 H106 F3 N18 O18 | Definition date: | 2012-12-12 | Last modified: | 2013-06-10 |
|
![PRD_000967 PRD_000967](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000967.svg) | PRD_000967 | Name: | macrocyclic peptidomimetic | Formula: | C56 H84 N16 O9 | Definition date: | 2013-03-06 | Last modified: | 2013-06-07 |
|
![PRD_000893 PRD_000893](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000893.svg) | PRD_000893 | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-15-(3-[METHYL(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-8-(2-METHYLPROPYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | Formula: | C54 H69 N7 O11 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000898 PRD_000898](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000898.svg) | PRD_000898 | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S,16S,19S,22S)-16-(3-AMINO-3-OXOPROPYL)-2,13-DIBENZYL-12,22-DIHYDROXY-3,5,17-TRIMETHYL-8-(2-METHYLPROPYL)-4,7,10,15,18,21-HEXAOXO-19-(PROPAN-2-YL)-3,6,9,14,17,20-HEXAAZATRICOSAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE (NON-PREFERRED NAME) | Formula: | C50 H74 N8 O12 | Definition date: | 2013-01-16 | Last modified: | 2013-06-03 |
|
![PRD_000899 PRD_000899](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000899.svg) | PRD_000899 | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-8-(2-METHYLPROPYL)-15-(3-[(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | Formula: | C53 H67 N7 O11 S | Definition date: | 2013-01-16 | Last modified: | 2013-06-03 |
|
![PRD_000910 PRD_000910](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000910.svg) | PRD_000910 | Name: | B4Z inhibitor | Formula: | C24 H44 N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000911 PRD_000911](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000911.svg) | PRD_000911 | Name: | C4Z inhibitor | Formula: | C27 H42 N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000912 PRD_000912](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000912.svg) | PRD_000912 | Name: | C6Z inhibitor | Formula: | C34 H54 N8 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000921 PRD_000921](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000921.svg) | PRD_000921 | Name: | Noxa BH3 peptide (cysteine-mediated cross-linked) | Formula: | C106 H179 N33 O25 S2 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000922 PRD_000922](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000922.svg) | PRD_000922 | Name: | PL-42 | Formula: | C39 H63 N9 O14 P S | Definition date: | 2013-04-03 | Last modified: | 2013-06-03 |
|
![PRD_000924 PRD_000924](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000924.svg) | PRD_000924 | Name: | Ac-DEVD-CMK | Formula: | C21 H33 Cl N4 O11 | Definition date: | 2013-05-08 | Last modified: | 2013-06-03 |
|
![PRD_000937 PRD_000937](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000937.svg) | PRD_000937 | Name: | peptide inhibitor | Formula: | C33 H50 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000940 PRD_000940](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000940.svg) | PRD_000940 | Name: | D-PHE-PRO-D-ARG-D-THR DERIVED DIRECT THROMBIN INHIBITOR | Formula: | C24 H39 N8 O5 | Definition date: | 2013-04-17 | Last modified: | 2013-06-03 |
|
![PRD_000941 PRD_000941](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000941.svg) | PRD_000941 | Name: | [Aba5,14]BTD-2 | Formula: | C80 H150 N36 O18 S4 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
![PRD_000184 PRD_000184](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000184.svg) | PRD_000184 | Name: | Microcin J25 | Formula: | C101 H140 N23 O27 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|